Altamira Therapeutics Ltd. Other Noncurrent Receivables
Altamira Therapeutics Ltd. (CYTOF) had Other Noncurrent Receivables of $103.34 thousand as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Receivables
ifrs-full:OtherNoncurrentReceivables · last filed 2025-04-30
- 2023-12-31: Other Noncurrent Receivables 80.00K CHF.
- 2022-12-31: Other Noncurrent Receivables 194.26K CHF.
- 2021-12-31: Other Noncurrent Receivables 199.10K CHF.
- 2020-12-31: Other Noncurrent Receivables 20.00K CHF.
CHF
| Period end | Other Noncurrent Receivables |
|---|---|
| 2023-12-31 | 80.00K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 194.26K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 199.10K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 20.00K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 20.00K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 16.00K CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 76.71K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 114.78K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Other Noncurrent Receivables |
|---|---|
| 2024-12-31 | $103.34K 20-F · filed 2025-04-30 |
| 2023-12-31 | $95.07K 20-F · filed 2025-04-30 |
| 2023-01-01 | $209.99K 20-F · filed 2025-04-30 |